Symptoms and cognition as predictors of community functioning: A prospective analysis

American Journal of Psychiatry

Volumn 156, Issue 3, 1999, Pages 400-405

  Norman, Ross M G ^a   Malla, Ashok K ^b   Cortese, Leonardo ^b   Cheng, Stephen ^b   Diaz, Kristine ^b   McIntosh, Elizabeth ^b   McLean, Terry S ^b   Rickwood, Ann ^b   Voruganti, L P ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COMMUNITY MENTAL HEALTH; HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RATING SCALE; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; COGNITION DISORDERS; COMMUNITY MENTAL HEALTH CENTERS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT;

EID: 0032975810     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kane JM, Marder SR: Psychopharmacological treatment of schizophrenia. Schizophr Bull 1993; 19:287-302
2. Marder SR, May PR: Benefits and limitations of neuroleptics - and other forms of treatment - in schizophrenia. Am J Psychother 1986; 40:357-369
3. Cassens G, Inglis AK, Appelbaum PS, Gutheil TG: Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr Bull 1990; 16:477-500
4. Green MF, Marshall BD Jr, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J: Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry 1997; 154:799-804
5. Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
6. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330
7. Johnstone EC, MacMillan JF, Frith CD, Benn DK, Crow TJ: Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry 1990; 157:182-189
8. Wykes T, Sturt E, Katz R: The prediction of rehabilitative success after three years: the use of social, symptom and cognitive variables. Br J Psychiatry 1990; 157:865-870
9. Goldman RS, Axelrod BN, Tandon R, Ribeiro SCM, Craig K, Berent S: Neuropsychological prediction of treatment efficacy and one-year outcome in schizophrenia. Psychopathology 1993; 126:122-126
10. Addington J, Addington D: Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J Psychiatry Neurosci 1993; 18:18-23
11. Breier A, Schreiber JL, Dyer J, Pickar D: National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48:239-246
12. Norman R, Malla AK, Morrison-Stewart SL, Helmes E, Williamson PC, Thomas J, Cortese L: Neuropsychological correlates of syndromes in schizophrenia. Br J Psychiatry 1997; 170:134-139
13. Rosen A, Hadzi-Pavlovic D, Parker G: The Life Skills Profile: a measure assessing function and disability in schizophrenia. Schizophr Bull 1989; 15:325-337
14. Liddle PF: The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br J Psychiatry 1987; 151:145-151
15. Malla AK, Norman RM, Williamson P, Cortese L, Diaz F: Three syndrome concept of schizophrenia: a factor analytic study. Schizophr Res 1993; 10:143-150
16. Spitzer RL, Williams JBW: Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1985
17. Berg EA: A simple objective treatment for measuring flexibility in thinking. J Gen Psychol 1948; 39:15-22
18. Morice R: Cognitive inflexibility and prefrontal dysfunction in schizophrenia and mania. Br J Psychiatry 1990; 157:50-54
19. Rey A: L'examen clinique en psychologie. Paris, Presses Universitaires de France, 1964
20. Wechsler D: Wechsler Memory Scale - Revised Manual. San Antonio, Tex, Psychological Corp, 1987
21. Benton AL: The Revised Visual Retention Test, 4th ed. New York, Psychological Corp, 1974
22. Taylor EM: Psychological Appraisal of Children With Cerebral Deficits. Cambridge, Mass, Harvard University Press, 1959
23. Jones-Gotman M, Milner B: Design fluency: the invention of nonsense drawings after focal cortical lesions. Neuropsychologia 1977; 15:653-674
24. Milner B: Some effects of frontal lobectomy in man, in The Frontal Granular Cortex and Behavior. Edited by Warren M, Akert K. New York, McGraw-Hill, 1964, pp 313-334
25. Kolb B, Whishaw I: Performance of schizophrenic patients on tests sensitive to left or right frontal temporal or parietal function in neurological patients. J Nerv Ment Dis 1983; 171:435-443
26. Andreasen NC: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1984
27. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
28. Liddle PF, Morris, DL: Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry 1991; 158:340-345
29. Spreen O, Strauss E: A Compendium of Neuropsychological Tests: Administration, Norms and Commentary, 2nd ed. New York, Oxford University Press, 1998
30. Goff DC, Shader RI: Non-neurological side effects of antipsychotic agents, in Schizophrenia. Edited by Hirsch SR, Weinberger DR. Oxford, UK, Blackwell Science, 1995, pp 566-584
31. Dickerson F, Boronow JJ, Ringel N, Parente F: Neurocognitive deficits and social functioning in outpatients with schizophrenia. Schizophr Res 1986; 21:75-83
32. Velligan DI, Mahurin RK, Diamond PL, Hazelton BC, Eckert SL, Miller AL: The functional significance of symptomatology and cognitive functioning in schizophrenia. Schizophr Res 1997; 25:21-31
33. Malla AK, Norman RMG, McLean TS, Cheng S, Rickwood A, McIntosh E, Cortese L, Diaz K, Voruganti LP: An integrated medical and psychosocial treatment program for psychotic disorders: patient characteristics and outcome. Can J Psychiatry 1998; 43:698-705
34. Hoffman H, Kupper Z: Relationships between social competence, psychopathology and work performance and their predictive value for vocational rehabilitation of schizophrenic out-patients. Schizophr Res 1997; 23:69-79
35. Marder SR, Davis JM, Chouinard G: The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 1997; 58:538-546